Hamilton J.
35
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neuropsicología | 5 |
| Farmacología | 2 |
| Neurología | 1 |
| Fisiología | 1 |
| Diabetes | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 5 |
| Fisiología humana | 3 |
| Enfermedades | 3 |
| Sistemas fisiológicos específicos de los animales | 1 |
| Microorganismos, hongos y algas | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| David Edward Komatsu | 5 |
| Thanos P.K. | 5 |
| Hadjiargyrou M. | 5 |
| Delis F. | 3 |
| Yao R. | 2 |
| Sajjad M. | 2 |
| Robison L.S. | 2 |
| Arnavut E. | 1 |
| Connor C. | 1 |
| Jalloh K. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding
ArticleAbstract: Aim: Examine the effects of chronic oral Methylphenidate (MP) treatment on the N-Methyl-D-aspartic aPalabras claves:ADOLESCENCE, methylphenidate, NMDA, ritalinAutores:David Edward Komatsu, Delis F., Hadjiargyrou M., Hamilton J., Jalloh K., Roeder N., Thanos P.K.Fuentes:scopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusChronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopus